| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 3,993 | 14,238 |
| Effect of exchange rate changes on cash and cash equivalents | 16,406 | 17,207 |
| Net decrease in cash and cash equivalents | -14,189 | -28,461 |
| Cash and cash equivalents at beginning of period | 246,375 | - |
| Cash and cash equivalents at end of period | 232,186 | - |
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)